2022 HAN Messages
- 0474 – 09/09/2022
Severe Respiratory Illnesses Associated with Rhinoviruses and/or Enteroviruses Including EV-D68 – Multistate, 2022 - 0473 – 08/30/2022
Variant Influenza Virus Infections: Recommendations for Identification, Treatment, and Prevention for Summer and Fall 2022 - 0472 – 07/30/2022
Update for Clinicians on Monkeypox in People with HIV, Children and Adolescents, and People who are Pregnant or Breastfeeding - 0471 – 07/28/2022
Update for Clinicians on Testing and Treatment for Monkeypox - 0470 – 07/27/2022
Melioidosis Locally Endemic in Areas of the Mississippi Gulf Coast after Burkholderia pseudomallei Isolated in Soil and Water and Linked to Two Cases – Mississippi, 2020 and 2022 - 0469 – 07/12/2022
Recent Reports of Human Parechovirus (PeV) in the United States—2022 - 0468 – 06/14/2022
Updated Case-finding Guidance: Monkeypox Outbreak—United States, 2022 - 0467 – 05/24/2022
COVID-19 Rebound After Paxlovid Treatment - 0466 – 05/20/2022
Monkeypox Virus Infection in the United States and Other Non-endemic Countries—2022 - 0465 – 05/11/2022
Updated Recommendations for Adenovirus Testing and Reporting of Children with Acute Hepatitis of Unknown Etiology - 0464 – 04/28/2022
Highly Pathogenic Avian Influenza A(H5N1) Virus: Recommendations for Human Health Investigations and Response - 0463 – 04/25/2022
Updated Information on Availability and Use of Treatments for Outpatients with Mild to Moderate COVID-19 Who are at Increased Risk for Severe Outcomes of COVID-19 - 0462 – 04/21/2022
Recommendations for Adenovirus Testing and Reporting of Children with Acute Hepatitis of Unknown Etiology
Additional Resources
Page last reviewed: March 28, 2019
Content source: Center for Preparedness and Response (CPR)